COVID-19 Updates

05 June 2020

Fourth update on BPL’s continued efforts during the COVID-19 pandemic

BPL is committed to giving regular updates on its key priorities guiding its response to COVID-19.

Read more

 

26 May 2020

Racing Against Time, Medical Researchers, Life Science Companies and COVID-19 Survivors Launch National Campaign to Drive Blood Plasma Donation

"The Fight Is In Us" Campaign Seeks to Mobilize COVID-19 Survivors to Accelerate the Development of Potentially Lifesaving Therapies.

Read more

 

06 May 2020

Third update on BPL’s work to ensure the provision of critical medicines in response to the COVID-19 pandemic

During the current COVID-19 pandemic, BPL is committed to giving regular updates.

Read more

 

07 April 2020

Further Update on BPL’s actions to ensure the provision of critical medicines in response to the worldwide COVID-19 pandemic

Participation in a new global alliance of plasma-derived therapeutic companies (including CSL Behring, Takeda, Octapharma, Biotest and LFB) to develop a hyperimmune immunoglobulin product targeting COVID-19.

Read more

 

06 April 2020

Global plasma leaders collaborate to accelerate development of potential Covid-19 hyperimmune therapy 

Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the global fight against COVID-19.

Read more

 

18 March 2020

Bio Products Laboratory Limited (“BPL”) 
COVID-19 and update on actions taken to ensure patient needs will continue to be met

Following the World Health Organisation’s (WHO) declaration that the COVID-19 Coronavirus outbreak is a pandemic, BPL is providing an update on actions taken to date to ensure that health care practitioners and patient needs around the world will continue to be met by the regular supply of our life-enhancing plasma-based products.

Read more